**********Anthropic $30B raise + $400M Coefficient Bio acquisition**********
Key Questions
What recent financing and acquisition has Anthropic confirmed?
Anthropic has confirmed a $30B financing round and an all-stock acquisition of Coefficient Bio for $400M. This deal expands into AI-driven biotech. The financing supports enterprise growth and compute expansion.
What are the details of Anthropic's compute deals with Google and Broadcom?
Anthropic has expanded its compute deals with Google and Broadcom to 3.5GW by 2027 amid high demand. These partnerships bolster infrastructure for AI scaling. They reinforce Anthropic's position in the AI market.
What is Anthropic's current valuation and IPO preparation status?
Anthropic is preparing for an IPO targeting a $400-500B valuation, with reports of a $600B private valuation. There is also $2B in secondary market activity involving DoD. This follows strong enterprise performance.
How does Anthropic compare to OpenAI in enterprise adoption?
Anthropic reports 70% new enterprise wins over OpenAI, with over 1,000 customers at $1M+ ARR and a potential $30B ARR run rate. Investors are pivoting to Anthropic amid OpenAI challenges. This signals a market shift favoring Anthropic.
What enterprise metrics highlight Anthropic's growth?
Anthropic has achieved over 1k+ customers with $1M ARR and is tracking toward a $30B ARR run rate. Secondary trading frenzy reached $2B, including DoD involvement. M&A and IPO prep are accelerating.
Confirmed $30B financing/all-stock acq + Google/Broadcom compute (3.5GW 2027); enterprise edge (70% new wins vs OpenAI)/$600B val/$2B secondary frenzy (DoD)/$30B ARR run rate?/1k+ $1M ARR. IPO prep $400-500B; M&A acceleration. Track LPs/terms/integration/secondaries/compute.